Logo image of NXU.DE

NEXUS AG (NXU.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:NXU - DE0005220909 - Common Stock

71.2 EUR
-0.1 (-0.14%)
Last: 11/24/2025, 7:00:00 PM
Fundamental Rating

6

Overall NXU gets a fundamental rating of 6 out of 10. We evaluated NXU against 11 industry peers in the Health Care Technology industry. NXU has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. NXU is valued quite expensive, but it does show an excellent growth. These ratings would make NXU suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year NXU was profitable.
In the past year NXU had a positive cash flow from operations.
NXU had positive earnings in each of the past 5 years.
NXU had a positive operating cash flow in each of the past 5 years.
NXU.DE Yearly Net Income VS EBIT VS OCF VS FCFNXU.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1.2 Ratios

The Return On Assets of NXU (6.93%) is comparable to the rest of the industry.
The Return On Equity of NXU (11.27%) is better than 63.64% of its industry peers.
With a Return On Invested Capital value of 8.35%, NXU perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for NXU is in line with the industry average of 9.28%.
The 3 year average ROIC (7.85%) for NXU is below the current ROIC(8.35%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.93%
ROE 11.27%
ROIC 8.35%
ROA(3y)6.17%
ROA(5y)6.42%
ROE(3y)9.56%
ROE(5y)10.69%
ROIC(3y)7.85%
ROIC(5y)8.2%
NXU.DE Yearly ROA, ROE, ROICNXU.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

NXU's Profit Margin of 12.11% is fine compared to the rest of the industry. NXU outperforms 72.73% of its industry peers.
In the last couple of years the Profit Margin of NXU has grown nicely.
The Operating Margin of NXU (15.41%) is better than 72.73% of its industry peers.
In the last couple of years the Operating Margin of NXU has grown nicely.
NXU's Gross Margin of 84.70% is fine compared to the rest of the industry. NXU outperforms 72.73% of its industry peers.
NXU's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.41%
PM (TTM) 12.11%
GM 84.7%
OM growth 3Y4.31%
OM growth 5Y3.41%
PM growth 3Y8.94%
PM growth 5Y9.93%
GM growth 3Y0.31%
GM growth 5Y-0.63%
NXU.DE Yearly Profit, Operating, Gross MarginsNXU.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

8

2. Health

2.1 Basic Checks

NXU has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, NXU has about the same amount of shares outstanding.
NXU has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NXU has an improved debt to assets ratio.
NXU.DE Yearly Shares OutstandingNXU.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
NXU.DE Yearly Total Debt VS Total AssetsNXU.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 5.57 indicates that NXU is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 5.57, NXU belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
The Debt to FCF ratio of NXU is 0.34, which is an excellent value as it means it would take NXU, only 0.34 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.34, NXU is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
NXU has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
NXU's Debt to Equity ratio of 0.05 is fine compared to the rest of the industry. NXU outperforms 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.34
Altman-Z 5.57
ROIC/WACC1.16
WACC7.21%
NXU.DE Yearly LT Debt VS Equity VS FCFNXU.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.3 Liquidity

NXU has a Current Ratio of 2.13. This indicates that NXU is financially healthy and has no problem in meeting its short term obligations.
NXU has a better Current ratio (2.13) than 72.73% of its industry peers.
A Quick Ratio of 2.08 indicates that NXU has no problem at all paying its short term obligations.
The Quick ratio of NXU (2.08) is better than 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 2.08
NXU.DE Yearly Current Assets VS Current LiabilitesNXU.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.97% over the past year.
NXU shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 20.97% yearly.
NXU shows a small growth in Revenue. In the last year, the Revenue has grown by 7.41%.
Measured over the past years, NXU shows a quite strong growth in Revenue. The Revenue has been growing by 12.11% on average per year.
EPS 1Y (TTM)26.97%
EPS 3Y17.9%
EPS 5Y20.97%
EPS Q2Q%-3.19%
Revenue 1Y (TTM)7.41%
Revenue growth 3Y11.59%
Revenue growth 5Y12.11%
Sales Q2Q%9.14%

3.2 Future

Based on estimates for the next years, NXU will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.50% on average per year.
Based on estimates for the next years, NXU will show a quite strong growth in Revenue. The Revenue will grow by 10.47% on average per year.
EPS Next Y14.6%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
EPS Next 5YN/A
Revenue Next Year9.04%
Revenue Next 2Y10.1%
Revenue Next 3Y10.39%
Revenue Next 5Y10.47%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
NXU.DE Yearly Revenue VS EstimatesNXU.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
NXU.DE Yearly EPS VS EstimatesNXU.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 36.14, NXU can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as NXU.
When comparing the Price/Earnings ratio of NXU to the average of the S&P500 Index (27.19), we can say NXU is valued slightly more expensively.
NXU is valuated quite expensively with a Price/Forward Earnings ratio of 32.24.
NXU's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of NXU to the average of the S&P500 Index (23.88), we can say NXU is valued slightly more expensively.
Industry RankSector Rank
PE 36.14
Fwd PE 32.24
NXU.DE Price Earnings VS Forward Price EarningsNXU.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NXU indicates a slightly more expensive valuation: NXU is more expensive than 63.64% of the companies listed in the same industry.
63.64% of the companies in the same industry are more expensive than NXU, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 21.76
EV/EBITDA 16.21
NXU.DE Per share dataNXU.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
NXU has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as NXU's earnings are expected to grow with 15.50% in the coming years.
PEG (NY)2.48
PEG (5Y)1.72
EPS Next 2Y14.95%
EPS Next 3Y15.5%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.32%, NXU is not a good candidate for dividend investing.
NXU's Dividend Yield is comparable with the industry average which is at 2.25.
Compared to an average S&P500 Dividend Yield of 1.94, NXU's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.32%

5.2 History

The dividend of NXU has a limited annual growth rate of 2.17%.
Dividend Growth(5Y)2.17%
Div Incr Years6
Div Non Decr Years6
NXU.DE Yearly Dividends per shareNXU.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

NXU pays out 11.69% of its income as dividend. This is a sustainable payout ratio.
NXU's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP11.69%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
NXU.DE Yearly Income VS Free CF VS DividendNXU.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NXU.DE Dividend Payout.NXU.DE Dividend Payout, showing the Payout Ratio.NXU.DE Dividend Payout.PayoutRetained Earnings

NEXUS AG

FRA:NXU (11/24/2025, 7:00:00 PM)

71.2

-0.1 (-0.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-04 2025-11-04
Earnings (Next)03-02 2026-03-02/amc
Inst Owners21.55%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.23B
Revenue(TTM)280.33M
Net Income(TTM)33.95M
Analysts45.71
Price Target71.4 (0.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.32%
Yearly Dividend0.22
Dividend Growth(5Y)2.17%
DP11.69%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 36.14
Fwd PE 32.24
P/S 4.39
P/FCF 21.76
P/OCF 18.33
P/B 4.08
P/tB 17.79
EV/EBITDA 16.21
EPS(TTM)1.97
EY2.77%
EPS(NY)2.21
Fwd EY3.1%
FCF(TTM)3.27
FCFY4.59%
OCF(TTM)3.88
OCFY5.46%
SpS16.23
BVpS17.45
TBVpS4
PEG (NY)2.48
PEG (5Y)1.72
Graham Number27.81
Profitability
Industry RankSector Rank
ROA 6.93%
ROE 11.27%
ROCE 11.14%
ROIC 8.35%
ROICexc 12.84%
ROICexgc 162.09%
OM 15.41%
PM (TTM) 12.11%
GM 84.7%
FCFM 20.15%
ROA(3y)6.17%
ROA(5y)6.42%
ROE(3y)9.56%
ROE(5y)10.69%
ROIC(3y)7.85%
ROIC(5y)8.2%
ROICexc(3y)12.19%
ROICexc(5y)11.45%
ROICexgc(3y)147.03%
ROICexgc(5y)150.84%
ROCE(3y)10.47%
ROCE(5y)10.94%
ROICexgc growth 3Y-0.23%
ROICexgc growth 5Y4.33%
ROICexc growth 3Y3.77%
ROICexc growth 5Y2.6%
OM growth 3Y4.31%
OM growth 5Y3.41%
PM growth 3Y8.94%
PM growth 5Y9.93%
GM growth 3Y0.31%
GM growth 5Y-0.63%
F-Score6
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.34
Debt/EBITDA 0.22
Cap/Depr 53.69%
Cap/Sales 3.78%
Interest Coverage 250
Cash Conversion 106.6%
Profit Quality 166.39%
Current Ratio 2.13
Quick Ratio 2.08
Altman-Z 5.57
F-Score6
WACC7.21%
ROIC/WACC1.16
Cap/Depr(3y)46.55%
Cap/Depr(5y)41.01%
Cap/Sales(3y)3.52%
Cap/Sales(5y)3.36%
Profit Quality(3y)122.34%
Profit Quality(5y)137.83%
High Growth Momentum
Growth
EPS 1Y (TTM)26.97%
EPS 3Y17.9%
EPS 5Y20.97%
EPS Q2Q%-3.19%
EPS Next Y14.6%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
EPS Next 5YN/A
Revenue 1Y (TTM)7.41%
Revenue growth 3Y11.59%
Revenue growth 5Y12.11%
Sales Q2Q%9.14%
Revenue Next Year9.04%
Revenue Next 2Y10.1%
Revenue Next 3Y10.39%
Revenue Next 5Y10.47%
EBIT growth 1Y16.23%
EBIT growth 3Y16.4%
EBIT growth 5Y15.93%
EBIT Next Year66.24%
EBIT Next 3Y29.63%
EBIT Next 5YN/A
FCF growth 1Y141.55%
FCF growth 3Y16.82%
FCF growth 5Y17.03%
OCF growth 1Y109.22%
OCF growth 3Y17.98%
OCF growth 5Y15.93%

NEXUS AG / NXU.DE FAQ

Can you provide the ChartMill fundamental rating for NEXUS AG?

ChartMill assigns a fundamental rating of 7 / 10 to NXU.DE.


What is the valuation status for NXU stock?

ChartMill assigns a valuation rating of 3 / 10 to NEXUS AG (NXU.DE). This can be considered as Overvalued.


Can you provide the profitability details for NEXUS AG?

NEXUS AG (NXU.DE) has a profitability rating of 7 / 10.


How financially healthy is NEXUS AG?

The financial health rating of NEXUS AG (NXU.DE) is 8 / 10.


What is the expected EPS growth for NEXUS AG (NXU.DE) stock?

The Earnings per Share (EPS) of NEXUS AG (NXU.DE) is expected to grow by 14.6% in the next year.